This blue chip is releasing its eagerly anticipated results next week. Here's what to expect. The post Own CSL shares? Here's ...
As CSL (ASX:CSL) rises 3.6% this past week, investors may now be noticing the company's five-year earnings growth ...
Two investment experts expect a big turnaround for CSL shares in 2025. The post 3 reasons to buy CSL shares today appeared ...
Approvals in the EU and US would be good news for CSL and its shares. That's because Goldman sees potential for garadacimab ...
Australia’s Therapeutic Goods Administration (TGA) has approved CSL Ltd.’s Andembry (garadacimab) for preventing recurrent ...
RBC Capital analyst Craig Wong-Pan maintained a Hold rating on CSL (CMXHF – Research Report) on January 29 and set a price target of A$286.00.
Goldman Sachs analyst Davinthra Thillainathan maintained a Buy rating on CSL (CMXHF – Research Report) today and set a price target of ...
Strengthening Connectivity Solutions for Demanding Operations CSL, the leading European provider of critical IoT connectivity, is pleased to announce ...
Clear Creek Financial Management LLC acquired a new stake in Carlisle Companies Incorporated (NYSE:CSL – Free Report) during the 4th quarter, according to its most recent 13F filing with the ...